LINC02454: A Drug Target / Disease Biomarker (G105369807)

Target Name: LINC02454

NCBI ID: G105369807

LINC02454

Other Name(s): Long intergenic non-protein coding RNA 2454 | long intergenic non-protein coding RNA 2454

LINC02454: A Drug Target / Disease Biomarker

LINC02454 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of LINC02454 is its ability to interact with a variety of different proteins, including the TGF-β1 receptor. This receptor is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues throughout the body. LINC02454 has been shown to play a key role in regulating the activity of TGF-β1, and is a potential drug target for a number of different diseases.

In addition to its role in cell growth and differentiation, LINC02454 is also involved in a number of other important processes in the body. For example, it has been shown to play a key role in regulating the movement of cells throughout the body, and is involved in the development and maintenance of the blood-brain barrier.

LINC02454 is also involved in a number of diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that LINC02454 is often expressed in various types of cancer, and that it is involved in the development and progression of these diseases. Additionally, LINC02454 has been implicated in a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Despite these promising findings, much more research is needed to fully understand the role of LINC02454 in the development and progression of disease. For example, it is not yet clear exactly how LINC02454 interacts with TGF-β1, or how it contributes to the regulation of cell growth and differentiation. Further studies are needed to fully understand the role of LINC02454 in these important processes, and to determine its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 2454

The "LINC02454 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02454 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets